NASUS PHARMA LTD ORD SHS is a security (CUSIP M7071P109) tracked across SEC portfolio filings. 10 institutional managers reported $4.7M on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Balyasny Asset Management L.P. | Chicago, IL | $2.0M | 898,473 |
| Cable Car Capital, LP | SAN FRANCISCO, CA | $1.3M | 601,998 |
| Velan Capital Investment Management LP | Alpharetta, GA | $798K | 359,390 |
| Hudson Bay Capital Management LP | Greenwich, CT | $299K | 134,771 |
| Bleichroeder LP | NEW YORK, NY | $199K | 89,848 |
| Empery Asset Management, LP | New York, NY | $102K | 45,803 |
| UBS Group AG | Zurich, V8 | $7K | 3,094 |
| MORGAN STANLEY | NEW YORK, NY | $4K | 2,000 |
| HRT FINANCIAL LP | NEW YORK, NY | $86 | 38,897 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $14 | 4 |